Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04777500 · ClinicalTrials.gov registry record · NA
taVNS Treatment for Fibromyalgia
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04777500: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT04777500 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04777500, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
In this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yard campus.
Interventions
- DEVICE Auricular transcutaneous electrical nerve stimulation device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-10-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04777500
The ClinicalTrials.gov registry entry for NCT04777500 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Auricular transcutaneous electrical nerve stimulation device is the first listed.
NCT04777500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04777500 about?
NCT04777500 is a clinical study titled "taVNS Treatment for Fibromyalgia". In this research study we want to learn more about if transcutaneous electrical nerve stimulation (TENS), a safe electrical stimulation tool, can relieve Fibromyalgia pain. A total of 60 subjects with Fibromyalgia will be enrolled in this study at Massachusetts General Hospital, Charlestown Navy Yar...
What is the current status of trial NCT04777500?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-10-03. Estimated completion is 2027-03.
What interventions are being tested in trial NCT04777500?
The interventions under investigation include: Auricular transcutaneous electrical nerve stimulation device (DEVICE).
Who is sponsoring clinical trial NCT04777500?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.